通知公告

2020年“圣和研究生创新成果奖”评审结果公示

发布时间:2020-11-10浏览次数:2124

    根据“学院圣和研究生创新成果奖评选实施细则(试行)”的内容及要求,学院成立工作组,收取审核材料,组织评审,经研究决定,以下学生获批2020年圣和研究生创新成果奖:

序号姓名学号学科专业论文题目刊物名称发表时间影响因子导师奖项等级奖金金额
1周济宇1731010055药物代谢动力学SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosisNATURE COMMUNICATIONS2020/1/1312.121郝海平特等
2王笛1731010044药物分析学Functional Metabolomics Reveal the Role of AHR/GPR35 Mediated Kynurenic acid Gradient Sensing in Chemotherapy-induced Intestinal DamageActa Pharmaceutica Sinica B2020.07.307.097许风国二等2000
3侯臣之1731010041药物分析学Estimating the prevalence of hepatitis B by wastewater-based epidemiology in 19 cities in ChinaScience of the Total Environment2020.5.236.551狄斌二等2000
4曾繁天1721010023药物化学Highly Specific Detection of Aβ Oligomers in Early Alzheimer’s Disease by Near-infrared Fluorescent Probe with a “V-shaped” Spatial ConformationChemical Communications2020.015.996(2020.06之后) 6.164(2020.06之前)李玉艳二等2000
5李翠翠1821010150药物分析学Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRASG12CEuropean Journal of Medicinal Chemistry2020.01.015.572狄斌三等1000
6高放1721010084药剂学Photoactivated Nanosheets Accelerate Nucleus Access of Cisplatin for Drug-Resistant Cancer TherapyAdvanced Functional Materials2020.01.0116.836孙敏捷三等1000
7周占威1731010023药剂学GSH depletion liposome adjuvant for augmenting the photothermal immunotherapy of breast cancerScience Advances2020.9.213.116孙敏捷三等1000
8彭亚运1831010018药剂学Activatable Core−Shell Metallofullerene: An Efficient Nanoplatform
for Bimodal Sensing of Glutathione
ACS Applied Materials & Interfaces2019.11.208.758蔡挺三等1000
9王红兰1721010094药剂学Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulationJournal of Controlled Release2020.02.077.727霍美蓉三等1000
10蒋志杰1721010139药剂学Jet-Lagged Nanoparticles Enhanced Immunotherapy Efficiency through Synergistic Reconstruction of Tumor Microenvironment and Normalized Tumor VasculatureAdvanced Healthcare Materials2020.4.287.367姚静三等1000
11程皓3119010032药剂学A Combinative Assembly Strategy Inspired Reversibly Borate-Bridged Polymeric Micelles for Lesion-Specific Rapid Release of Anti-Coccidial DrugsNano-Micro Letters2020.7.2512.264丁杨三等1000
12朱颖3119010047药剂学Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug deliveryBiomaterials Science2020.08.126.183葛亮三等1000
13李昭廷1731010027药剂学Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapyScience Advances2020.7.2613.116David Oupicky三等1000
14王奕欣1721010098药剂学Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexesJournal of Controlled Release2019.10.207.727David Oupicky三等1000
15杨一飞1631010007药物化学Identification of 3,5-Dimethylisoxazole Derivatives as BRD4
Inhibitors for the Treatment of Colorectal Cancer
ACS Medicinal Chemistry Letters2020.7.273.975周金培三等1000
16徐鹏飞1831010012药物化学Practical and Efficient Approach to the Preparation of Diquafosol TetrasodiumOrg. Process Res. Dev.2019.10.213.023李志裕三等1000
17余荩颖1721010066药物化学Discovery of Potent, Selective, and Direct Acid Sphingomyelinase Inhibitors with Antidepressant ActivityJournal of Medicinal Chemistry2020.01.166.205王进欣三等1000
18张文婷1722010289药学Discovery of Aryl Formyl Piperidine Derivatives as Potent,Reversible, and Selective Monoacylglycerol Lipase InhibitorsJournal of Medicinal Chemistry2020.05.206.205王进欣三等1000
19孔维敏1831010057药物代谢动力学Physiologically based pharmacokinetic–pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans Acta Pharmacologica Sinica2020.1.225.064刘晓东三等1000
20杨逸婷3120010079药物代谢动力学Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and EnzymesInternational Journal of Molecular Sciences2020.09.184.556刘晓东三等1000
21程兆炎1831010047药理学Dopamine D1 receptor agonist A-68930 ameliorates Aβ1-42-induced cognitive impairment and neuroinflammation in miceInternational Immunopharmacology2020.9.103.943何玲三等1000

    公示时间为:2020年11月10日至2020年11月13日止,如有问题,请联系澳门十大老牌信誉平台排行榜办公室025-86185328,最终解释权归澳门十大老牌信誉平台排行榜所有。


澳门十大老牌信誉平台排行榜
2020年11月10日

 

Baidu
sogou